🇺🇸 Macrolides in United States
51 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 51
Most-reported reactions
- Drug Interaction — 7 reports (13.73%)
- Dyspnoea — 7 reports (13.73%)
- Fatigue — 5 reports (9.8%)
- Hypersensitivity — 5 reports (9.8%)
- Nausea — 5 reports (9.8%)
- Pain — 5 reports (9.8%)
- Pneumonia — 5 reports (9.8%)
- Anaphylactic Reaction — 4 reports (7.84%)
- Dehydration — 4 reports (7.84%)
- Hallucination — 4 reports (7.84%)
Other Other approved in United States
Frequently asked questions
Is Macrolides approved in United States?
Macrolides does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Macrolides in United States?
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology is the originator. The local marketing authorisation holder may differ — check the official source linked above.